Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038091
Filing Date
2024-03-28
Accepted
2024-03-28 16:30:53
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eldn-20231231.htm   iXBRL 10-K 2507321
2 EX-10.22 eldn-ex10_22.htm EX-10.22 45419
3 EX-10.23 eldn-ex10_23.htm EX-10.23 24637
4 EX-23.1 eldn-ex23_1.htm EX-23.1 5540
5 EX-31.1 eldn-ex31_1.htm EX-31.1 15595
6 EX-31.2 eldn-ex31_2.htm EX-31.2 15833
7 EX-32.1 eldn-ex32_1.htm EX-32.1 8219
8 EX-32.2 eldn-ex32_2.htm EX-32.2 8201
9 EX-97.1 eldn-ex97_1.htm EX-97.1 23204
10 GRAPHIC img116206746_0.jpg GRAPHIC 868165
11 GRAPHIC img116206746_1.jpg GRAPHIC 337080
12 GRAPHIC img116206746_2.jpg GRAPHIC 142341
13 GRAPHIC img116206746_3.jpg GRAPHIC 119803
  Complete submission text file 0000950170-24-038091.txt   12870749

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20231231.xsd EX-101.SCH 1330774
84 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20231231_htm.xml XML 1557331
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36620 | Film No.: 24799595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)